Rafarma Pharmaceuticals Stock Price on December 11, 2023
| RAFA Stock | USD 0.06 0.01 8.96% |
If you're considering investing in Rafarma Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Rafarma Pharmaceuticals stands at 0.06, as last reported on the 16th of December 2024, with the highest price reaching 0.08 and the lowest price hitting 0.06 during the day. Rafarma Pharmaceuticals is out of control given 3 months investment horizon. Rafarma Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.6% are justified by taking the suggested risk. Use Rafarma Pharmaceuticals Coefficient Of Variation of 850.13, semi deviation of 9.7, and Risk Adjusted Performance of 0.0948 to evaluate company specific risk that cannot be diversified away.
Rafarma Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Rafarma |
Sharpe Ratio = 0.1153
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | RAFA | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 13.88 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.6 actual daily | 31 69% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Rafarma Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rafarma Pharmaceuticals by adding it to a well-diversified portfolio.
Rafarma Pharmaceuticals Valuation on December 11, 2023
It is possible to determine the worth of Rafarma Pharmaceuticals on a given historical date. On December 11, 2023 Rafarma was worth 0.35 at the beginning of the trading date compared to the closed value of 0.38. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rafarma Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Rafarma Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rafarma Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rafarma Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.29 | 0.37 | 0.29 | 0.36 | 344,300 | |
12/11/2023 | 0.35 | 0.40 | 0.35 | 0.38 | 319,800 |
| 0.38 | 0.43 | 0.38 | 0.38 | 53,600 |
| Backtest Rafarma Pharmaceuticals | | | Rafarma Pharmaceuticals History | | | Rafarma Pharmaceuticals Valuation | Previous | Next |
Rafarma Pharmaceuticals Trading Date Momentum on December 11, 2023
| On December 12 2023 Rafarma Pharmaceuticals was traded for 0.38 at the closing time. The top price for the day was 0.43 and the lowest listed price was 0.38 . The trading volume for the day was 53.6 K. The trading history from December 12, 2023 did not cause price change. The trading delta at closing time against the current closing price is 13.16% . |
Rafarma Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Rafarma Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rafarma Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rafarma financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Rafarma Pharmaceuticals Pink Sheet history
Rafarma Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rafarma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rafarma Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rafarma Pharmaceuticals stock prices may prove useful in developing a viable investing in Rafarma Pharmaceuticals
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. D. RAFARMA PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Rafarma Pharmaceuticals Pink Sheet Technical Analysis
Rafarma Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Rafarma Pharmaceuticals Period Price Range
Low | December 16, 2024
| High |
0.00 | 0.00 |
Rafarma Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Rafarma Pharmaceuticals December 16, 2024 Market Strength
Market strength indicators help investors to evaluate how Rafarma Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rafarma Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rafarma Pharmaceuticals pink sheet market strength indicators, traders can identify Rafarma Pharmaceuticals entry and exit signals to maximize returns
Rafarma Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rafarma Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Rafarma Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rafarma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0948 | |||
| Jensen Alpha | 1.65 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1054 | |||
| Treynor Ratio | 2.48 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Rafarma Pink Sheet analysis
When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |